VITAMINE C - INTRAVENOUS THERAPY

The initial impetus in vitamine C intravenous, was from Linus Pauling (Nobel Prize) who, together with Ewan Cameron, pioneered the use of high-dose C in degenerative diseases in the 1960s.

Now, there’s new interest in this modality for fighting cancer based on new, exciting research under way at the National Institutes of Health.

Cameron and Pauling found that vitamin C helped cancer patients live about four times longer than cancer patients not given vitamin C. They administered high-dose vitamin C in the form of sodium ascorbate given orally and intravenously to treat more than 1,000 cancer patients.

Alternative practitioners, meanwhile, sought to resurrect IV vitamin C as a tool in the treatment of cancer, but not until recently has serious academic research resumed.

Many doctors of Integrative Medicine, has undertaken a series of clinical trials to validate the benefits of IV vitamin C in cancer. An FDA approved trial is now underway.

Research at the National Institutes of Health is beginning to suggest that vitamin C deserves another chance to find its niche in the arsenal of anti-cancer therapies,various degenerative diseases.

When vitamin C given intravenously is delivered in a “drip,” much higher concentrations of C can be attained. At these higher concentrations, vitamin C has different characteristics than if given orally. While oral vitamin C boosts immunity and assists tissue repair, but it is too weak to do much to kill or inhibit cancer cells. High doses delivered directly into the bloodstream, it may act to increase levels of hydrogen peroxide deep in the tissues where cancer cells lurk.

Vitamin C, when administered by a trained, experienced physician, is safe and well-tolerated, Proper blood tests must be done to ensure that it is well-tolerated, . Doses must be gradually adjusted upward. Not all patients are candidates for IV vitamin C. Vitamin C can be safely administered even while patients are undergoing chemo and radiation; in fact, the FDA-approved trial at the University of Kansas Medical Center explicitly permits the co-administration of vitamin C with conventional treatments.

Intravenous vitamin C is support of recovery from cancer, and it is hoped that additional research, now under way, will further document its benefits.